Serum Institute of India (SII)

Pune: Amid the shortage of Covid vaccines in the country, Serum Institute of India (SII) has informed the government on Sunday that it shall provide around 10 Crore of Covishield in the month of June. The employees have been working…
Read More...

New Delhi: Serum Institute of India CEO Adar Poonawalla has said that the SII never exported vaccines at the cost of the people in India. Defending the move to export vaccines earlier this year by the government and vaccine manufacturers…
Read More...

New Delhi: The Ministry of Health and Family Welfare (MoHFW) has made a modification in the Co-WIN online portal for the second dose of Covishield Covid vaccine from Wednesday. The Health Ministry has informed regarding the above stated…
Read More...

Mumbai: A criminal petition has been filed in Bombay High Court seeking Z+ security cover for Adar Poonawalla, Chief Executive Officer of the Serum Institute of India (SII) which manufactures Covishield vaccine. The petition has been…
Read More...

New Delhi: Amid the shortage of vaccines against Covid-19 in India, Chief Executive Officer ( CEO ) of Serum Institute of India (SII) Adar Poonawalla has said that the issue shall continue till the month of July. The capacity shall be…
Read More...

Bhubaneswar: Keeping in mind the rising cases of Covid-19 in India the CEO of Serum Institute Of India, Adar Poonawalla has reduced the price of Covishield vaccine for the States. Henceforth, the vaccines will be sold to the states for…
Read More...

New Delhi: The Serum Institute of India (SII) on Saturday broke its silence over the pricing of its Covid-19 vaccine 'Covishield' and said that it is the most affordable vaccine available in the market today. SII, which manufactures the…
Read More...

Bhubaneswar: Serum Institute of India (SII) has announced the price of Covishield vaccine at Rs 600 per dose for private hospitals and Rs 400 for state government from May 1 that will include vaccinations for all above 18 years of age.…
Read More...

Serum Institute of India CEO Adar Poonawalla informed that the trials of Covovax in India have started. Covovax vaccine is being developed in partnership with American vaccine developer Novavax. Taking to his Twitter handle, Poonawalla…
Read More...

Bhubaneswar: Private hospitals and companies will get Covid 19 vaccines by March 2021, said Chief Executive Officer of the Serum Institute of India (SII) Adar Poonawalla. SII has made 5 crore doses of the Oxford University-AstraZeneca…
Read More...